Brendan Martin Mulshine Sells 30,000 Shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN) Stock

Ryan Specialty Holdings, Inc. (NYSE:RYAN) EVP Brendan Martin Mulshine sold 30,000 shares of Ryan Specialty stock in a transaction dated Friday, March 14th. The stock was sold at an average price of $69.30, for a total value of $2,079,000.00. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.

Ryan Specialty Stock Down 0.4 %

NYSE:RYAN opened at $71.08 on Wednesday. The stock’s fifty day moving average price is $67.51 and its two-hundred day moving average price is $67.86. Ryan Specialty Holdings, Inc. has a 52-week low of $48.48 and a 52-week high of $75.97. The company has a debt-to-equity ratio of 2.40, a quick ratio of 1.01 and a current ratio of 1.01. The company has a market cap of $18.62 billion, a price-to-earnings ratio of 103.01, a P/E/G ratio of 1.19 and a beta of 0.71.

Ryan Specialty (NYSE:RYAN) last posted its quarterly earnings data on Thursday, February 20th. The company reported $0.45 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.47 by ($0.02). The firm had revenue of $663.53 million for the quarter, compared to analyst estimates of $658.80 million. Ryan Specialty had a return on equity of 48.01% and a net margin of 9.14%. On average, analysts anticipate that Ryan Specialty Holdings, Inc. will post 2.29 EPS for the current year.

Ryan Specialty Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Tuesday, March 4th were given a dividend of $0.12 per share. This is a boost from Ryan Specialty’s previous quarterly dividend of $0.11. The ex-dividend date was Tuesday, March 4th. This represents a $0.48 annualized dividend and a dividend yield of 0.68%. Ryan Specialty’s payout ratio is presently 69.57%.

Institutional Trading of Ryan Specialty

Several institutional investors and hedge funds have recently made changes to their positions in the business. Wealth Enhancement Advisory Services LLC raised its position in shares of Ryan Specialty by 3.7% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 11,755 shares of the company’s stock valued at $754,000 after acquiring an additional 420 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in shares of Ryan Specialty by 14.1% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 299,156 shares of the company’s stock valued at $19,194,000 after acquiring an additional 36,990 shares during the last quarter. Voloridge Investment Management LLC increased its position in shares of Ryan Specialty by 4.7% in the 4th quarter. Voloridge Investment Management LLC now owns 609,995 shares of the company’s stock valued at $39,137,000 after buying an additional 27,657 shares in the last quarter. Sone Capital Management LLC bought a new stake in shares of Ryan Specialty in the 4th quarter valued at $8,303,000. Finally, Waters Parkerson & CO. LLC increased its position in shares of Ryan Specialty by 9.9% in the 4th quarter. Waters Parkerson & CO. LLC now owns 358,710 shares of the company’s stock valued at $23,015,000 after buying an additional 32,380 shares in the last quarter. Institutional investors own 84.82% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have commented on RYAN shares. Keefe, Bruyette & Woods cut their price target on shares of Ryan Specialty from $77.00 to $76.00 and set an “outperform” rating for the company in a research note on Friday, February 21st. Morgan Stanley started coverage on Ryan Specialty in a report on Thursday, December 5th. They issued an “overweight” rating and a $90.00 target price on the stock. Wells Fargo & Company boosted their target price on Ryan Specialty from $64.00 to $69.00 and gave the stock an “equal weight” rating in a report on Friday, February 21st. UBS Group boosted their target price on Ryan Specialty from $82.00 to $84.00 and gave the stock a “buy” rating in a report on Wednesday, February 26th. Finally, Barclays boosted their target price on Ryan Specialty from $76.00 to $88.00 and gave the stock an “overweight” rating in a report on Thursday, November 21st. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and six have given a buy rating to the company’s stock. Based on data from MarketBeat, Ryan Specialty presently has an average rating of “Hold” and a consensus target price of $75.27.

About Ryan Specialty

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.